amn adrenomyeloneuropathy glutathione To learn more, visit: https://www.clinicaltrials.gov/study/NCT05819866 A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male Subjects With Cerebral Adrenoleukodystrophy (CALYX) Sponsored by: Minoryx Therapeutics ALD Phenotypes: Adrenomyeloneuropathy (AMN) |
ALD Phenotypes: Adrenomyeloneuropathy (AMN) ALD Connect Revisiting the Pathogenesis of X Linked Adrenoleukodystrophy Amen Glutathione SR+ AMN Adrenomyeloneuropathy Alex The Leukodystrophy Charity Management of adrenoleukodystrophy: From pre clinical studies to the development of new therapies ScienceDirect
Pay in 4 interest-free payments of $6.44 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18




